The previous Imaging and Engineering Cores have been combined into a new Core. Although larger and more complex than separate Cores, the new combined core design will better serve the needs of the Program by integrating imaging and engineering resources. This integration has become even more important since the development of the combined MRI / regional hyperthermia system. The Core will provide a broad range of services to the Program. The Core will provide routine technical support, quality assurance, and Radiological expertise for the imaging studies of the Program, including the dynamic MRI studies, MRS, and PET/CT studies (Project 5), the in-vivo rodent MRI liposome studies (Project 3), and dynamic CT studies in canine patients (Project 4). In addition, the Core will provide engineering support and expertise for the hyperthermia treatments (Project 5) and phantom experiments (Projects 1 and 2) of the Program, including quality assurance of invasive and non-invasive MR-based thermometry. Finally, the Core will provide ongoing development and improvement in imaging techniques and hyperthermia equipment over the course of the Program. The overall objective of the Core is to provide imaging and engineering support for non-invasive assessment of heat-induced changes in tumor physiology, and to provide the combined imaging and engineering expertise required for image-based hyperthermia treatment planning and MR-based feedbackcontrolled hyperthermia delivery.
Specific Aim 1 - The Core will provide technical support, quality assurance, and Radiological expertise for the clinical and experimental imaging studies of the Program Specific Aim 2 - The Core will provide technical and engineering support during the hyperthermia treatments and phantoexperiments in the Program Specific Aim 3 - The Core will develop improvements in imaging techniques, provide technical advances in the hyperthermia equipment, and updates in technology as they evolve throughout the course of the Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA042745-23
Application #
7881445
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
23
Fiscal Year
2009
Total Cost
$466,749
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Stauffer, Paul R; van Rhoon, Gerard C (2016) Overview of bladder heating technology: matching capabilities with clinical requirements. Int J Hyperthermia 32:407-16
Juang, Titania; Stauffer, Paul R; Craciunescu, Oana A et al. (2014) Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia 30:176-83
Inman, Brant A; Stauffer, Paul R; Craciunescu, Oana A et al. (2014) A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 30:171-5
Angele, Martin K; Albertsmeier, Markus; Prix, Niclas J et al. (2014) Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg 260:749-54; discussion 754-6
Zagar, Timothy M; Vujaskovic, Zeljko; Formenti, Silvia et al. (2014) Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer. Int J Hyperthermia 30:285-94
Viglianti, Benjamin L; Dewhirst, Mark W; Boruta, R J et al. (2014) Systemic anti-tumour effects of local thermally sensitive liposome therapy. Int J Hyperthermia 30:385-92
Oliveira, Tiago R; Stauffer, Paul R; Lee, Chen-Ting et al. (2013) Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study. Int J Hyperthermia 29:835-44
Dewhirst, Mark W; Landon, Chelsea D; Hofmann, Christina L et al. (2013) Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes. Surg Oncol Clin N Am 22:545-61
Oliveira, Tiago R; Stauffer, Paul R; Lee, Chen-Ting et al. (2013) Preclinical Dosimetry of Magnetic Fluid Hyperthermia for Bladder Cancer. Proc SPIE Int Soc Opt Eng 8584:1656985
van Rhoon, Gerard C; Samaras, Theodoros; Yarmolenko, Pavel S et al. (2013) CEM43°C thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels? Eur Radiol 23:2215-27

Showing the most recent 10 out of 227 publications